FIRST APPROVED THERAPY
Auxilium stock up on FDA approval of Peyronie’s therapy
By Catherine Shaffer
Friday, December 6, 2013
The FDA approved Xiaflex (collagenase clostridium histolyticum) for Peyronie’s disease, making it the first approved therapy for the condition, which is characterized by abnormal tissue in the penis, causing a curvature deformity of at least 30 degrees upon erection.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.